DeepMed Research

Tulane University School of Medicine

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1834-01-01

Employees: 1K

Market Cap: -

Website: https://medicine.tulane.edu

Clinical Trials

To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study

Phase 4

Completed

Conditions: Diabetes Mellitus, Non-Insulin-Dependent
Hypertensive Disease

Interventions: Drug: Liraglutide or Placebo

First Posted Date: 2014-11-24

Last Posted Date: 2021-01-27

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 11

Registration Number: NCT02299388

Locations: 🇺🇸
Tulane University Health Science Center, Tidewater building and Tulane Hospital and Clinics, New Orleans, Louisiana, United States

Safety of Lactobacillus Reuteri in Healthy Children Ages 2 to 5 Years in Peru

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: Placebo
Biological: Lactobacillus reuteri

First Posted Date: 2014-04-28

Last Posted Date: 2017-04-24

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 60

Registration Number: NCT02124122

Locations: 🇵🇪
Community of Santa Clara, Santa Clara, Loreto, Peru

Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

Phase 4

Completed

Conditions: Type 2 Diabetes
Hypertension

Interventions: Drug: amlodipine, hydralazine, terazosin or hydrochlorothiazide

First Posted Date: 2014-01-27

Last Posted Date: 2023-08-21

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 28

Registration Number: NCT02046395

Locations: 🇺🇸
Tulane University Health Sciences Center, New Orleans, Louisiana, United States

Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients

Not Applicable

Completed

Conditions: Colorectal Cancer
Cervical Cancer
Breast Cancer

Interventions: Other: Cancer risk communication skills training

First Posted Date: 2011-05-26

Last Posted Date: 2017-03-10

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 168

Registration Number: NCT01361035

Locations: 🇺🇸
Tulane Faculty Practice, New Orleans, Louisiana, United States
🇺🇸
Tulane Communty Health Center at Covenant House, New Orleans, Louisiana, United States
🇺🇸
DCSNO St Cecelia Medical Center, New Orleans, Louisiana, United States

and more 2 locations

Diabetes Remote Care Management System

Not Applicable

Completed

Conditions: Diabetes

Interventions: Device: DRMS

First Posted Date: 2011-05-16

Last Posted Date: 2017-05-09

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 98

Registration Number: NCT01354015

Locations: 🇺🇸
Tulane University, New Orleans, Louisiana, United States

Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan Nonresponders

Completed

Conditions: PAH Gene Expression
Phenylketonuria
Behavior and Behavior Mechanisms

Interventions: Drug: sapropterin dihydrochloride

First Posted Date: 2011-01-11

Last Posted Date: 2023-08-14

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 21

Registration Number: NCT01274026

Locations: 🇺🇸
Tulane University Health Science Center, New Orleans, Louisiana, United States

Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth

Phase 2

Completed

Conditions: Posttraumatic Stress Disorders
PTSD

Interventions: Drug: Placebo pill
Drug: D-cycloserine
Behavioral: CBT

First Posted Date: 2010-07-07

Last Posted Date: 2017-04-21

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 33

Registration Number: NCT01157416

Locations: 🇺🇸
Tulane University Health Sciences Center, 1440 Canal St., New Orleans, Louisiana, United States

D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents

Phase 2

Completed

Conditions: Posttraumatic Stress Disorder
PTSD

Interventions: Drug: Placebo pill
Drug: D-cycloserine
Behavioral: CBT

First Posted Date: 2010-07-07

Last Posted Date: 2017-06-06

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 24

Registration Number: NCT01157429

Locations: 🇺🇸
Tulane University Health Sciences Center, 1440 Canal St., New Orleans, Louisiana, United States

Safety of Lactobacillus Reuteri in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: Lactobacillus reuteri
Other: Placebo

First Posted Date: 2008-10-17

Last Posted Date: 2016-12-19

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 45

Registration Number: NCT00774163

Locations: 🇵🇪
Community of Santa Clara, Iquitos, Loreto, Peru

Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors

Phase 2

Completed

Conditions: Hemophilia A With Inhibitors

Interventions: Drug: activated prothrombin complex concentrate (FEIBA)

First Posted Date: 2005-09-22

Last Posted Date: 2020-03-02

Lead Sponsor: Tulane University School of Medicine

Target Recruit Count: 34

Registration Number: NCT00221195

Locations: 🇺🇸
Tulane University School of Medicine, New Orleans, Louisiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy